Durvalumab
Neues Anwendungsgebiet: Adenokarzinom des Magens oder des gastroösophagealen Übergangs, neoadjuvante und adjuvante Kombination mit FLOT-Chemotherapie gefolgt von adjuvanter Monotherapie
- Brand
- Imfinzi
- Manufacturer
- AstraZeneca GmbH
G-BA action
no public decision loaded
No decision date loaded
Verfahren begonnen
No public G-BA decision is attached to this loaded case record.
Official case record
What happened, in source order
No inferred stages
Consultation record
Oral hearing and Wortprotokoll
No official oral hearing is attached to this case.
IQWiG comparison
Assessment record versus G-BA action
IQWiG assessment findings and the later G-BA action are separate records. Open both to compare them.
No IQWiG assessment reference is present on the validated official case page. This is an explicit absence, not a broken graph link.
G-BA decisions
Distinct actions and documents
The official case is active or pending. No associated decision is loaded for this validated record.
Official sources